Metabolic response of blood vessels to TNFα

  1. Abidemi Junaid
  2. Johannes Schoeman
  3. Wei Yang
  4. Wendy Stam
  5. Alireza Mashaghi
  6. Anton Jan van Zonneveld
  7. Thomas Hankemeier  Is a corresponding author
  1. Leiden University, Netherlands
  2. Leiden University Medical Center, Netherlands

Abstract

TNFa signaling in the vascular endothelium elicits multiple inflammatory responses that drive vascular destabilization and leakage. Bioactive lipids are main drivers of these processes. In vitro mechanistic studies of bioactive lipids have been largely based on two-dimensional endothelial cell cultures that, due to lack of laminar flow and the growth of the cells on non-compliant stiff substrates, often display a pro-inflammatory phenotype. This complicates the assessment of inflammatory processes. Three-dimensional microvessels-on-a-chip models provide a unique opportunity to generate endothelial microvessels in a more physiological environment. Using an optimized targeted liquid chromatography-tandem mass spectrometry measurements of a panel of pro- and anti-inflammatory bioactive lipids, we measure the profile changes upon administration of TNFa. We demonstrate that bioactive lipid profiles can be readily detected from three-dimensional microvessels-on-a-chip and display a more dynamic, less inflammatory response to TNFa, that resembles more the human situation, compared to classical two-dimensional endothelial cell cultures.

Data availability

The data used to generate the figures and tables can be found in the Source Data File.

Article and author information

Author details

  1. Abidemi Junaid

    Systems Pharmacology Cluster, Analytical Biosciences, LACDR, Leiden University, Leiden, Netherlands
    Competing interests
    No competing interests declared.
  2. Johannes Schoeman

    Systems Pharmacology Cluster, Analytical Biosciences, LACDR, Leiden University, Leiden, Netherlands
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0905-2467
  3. Wei Yang

    Systems Pharmacology Cluster, Analytical Biosciences, LACDR, Leiden University, Leiden, Netherlands
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3394-7570
  4. Wendy Stam

    Department of Internal Medicine (Nephrology), Leiden University Medical Center, Leiden, Netherlands
    Competing interests
    No competing interests declared.
  5. Alireza Mashaghi

    Systems Pharmacology Cluster, Medical Systems Biophysics and Bioengineering, LACDR, Leiden University, Leiden, Netherlands
    Competing interests
    No competing interests declared.
  6. Anton Jan van Zonneveld

    Department of Internal Medicine (Nephrology), Leiden University Medical Center, Leiden, Netherlands
    Competing interests
    No competing interests declared.
  7. Thomas Hankemeier

    Systems Pharmacology Cluster, Analytical Biosciences, LACDR, Leiden University, Leiden, Netherlands
    For correspondence
    hankemeier@lacdr.leidenuniv.nl
    Competing interests
    Thomas Hankemeier, TH is co-founder of MIMETAS and has some shares in MIMETAS..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7871-2073

Funding

Hartstichting (RECONNECT CVON Groot)

  • Abidemi Junaid
  • Anton Jan van Zonneveld
  • Thomas Hankemeier

ZonMw (114022501)

  • Abidemi Junaid
  • Anton Jan van Zonneveld
  • Thomas Hankemeier

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (16249)

  • Alireza Mashaghi
  • Thomas Hankemeier

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Arduino A Mangoni, Flinders Medical Centre, Australia

Version history

  1. Received: December 27, 2019
  2. Accepted: August 2, 2020
  3. Accepted Manuscript published: August 4, 2020 (version 1)
  4. Version of Record published: September 7, 2020 (version 2)

Copyright

© 2020, Junaid et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,297
    Page views
  • 337
    Downloads
  • 12
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Abidemi Junaid
  2. Johannes Schoeman
  3. Wei Yang
  4. Wendy Stam
  5. Alireza Mashaghi
  6. Anton Jan van Zonneveld
  7. Thomas Hankemeier
(2020)
Metabolic response of blood vessels to TNFα
eLife 9:e54754.
https://doi.org/10.7554/eLife.54754

Share this article

https://doi.org/10.7554/eLife.54754

Further reading

    1. Medicine
    Hong Chen, Lijun Sun ... Yue Yin
    Research Article

    Mechanism underlying the metabolic benefit of intermittent fasting remains largely unknown. Here, we reported that intermittent fasting promoted interleukin-22 (IL-22) production by type 3 innate lymphoid cells (ILC3s) and subsequent beigeing of subcutaneous white adipose tissue. Adoptive transfer of intestinal ILC3s increased beigeing of white adipose tissue in diet-induced-obese mice. Exogenous IL-22 significantly increased the beigeing of subcutaneous white adipose tissue. Deficiency of IL-22 receptor (IL-22R) attenuated the beigeing induced by intermittent fasting. Single-cell sequencing of sorted intestinal immune cells revealed that intermittent fasting increased aryl hydrocarbon receptor signaling in ILC3s. Analysis of cell-cell ligand receptor interactions indicated that intermittent fasting may stimulate the interaction of ILC3s with dendritic cells and macrophages. These results establish the role of intestinal ILC3s in beigeing of white adipose tissue, suggesting that ILC3/IL-22/IL-22R axis contributes to the metabolic benefit of intermittent fasting.

    1. Medicine
    2. Neuroscience
    Marvin Petersen, Felix Hoffstaedter ... Bastian Cheng
    Research Article

    The link between metabolic syndrome (MetS) and neurodegenerative as well as cerebrovascular conditions holds substantial implications for brain health in at-risk populations. This study elucidates the complex relationship between MetS and brain health by conducting a comprehensive examination of cardiometabolic risk factors, brain morphology, and cognitive function in 40,087 individuals. Multivariate, data-driven statistics identified a latent dimension linking more severe MetS to widespread brain morphological abnormalities, accounting for up to 71% of shared variance in the data. This dimension was replicable across sub-samples. In a mediation analysis, we could demonstrate that MetS-related brain morphological abnormalities mediated the link between MetS severity and cognitive performance in multiple domains. Employing imaging transcriptomics and connectomics, our results also suggest that MetS-related morphological abnormalities are linked to the regional cellular composition and macroscopic brain network organization. By leveraging extensive, multi-domain data combined with a dimensional stratification approach, our analysis provides profound insights into the association of MetS and brain health. These findings can inform effective therapeutic and risk mitigation strategies aimed at maintaining brain integrity.